Pharmacopoeial Discussion Group Achievements

EDQM 27/10/2023 Strasbourg, France

The Pharmacopoeial Discussion Group (PDG) held its annual autumn meeting from 3 to 4 October 2023. The group welcomed the Indian Pharmacopoeia Commission (IPC) as a new member during the meeting (link). The addition of the IPC, a first in the over 34-year history of the PDG, facilitates the reach...

Read More

EDQM joins efforts to tackle medicine shortages

EDQM 11/10/2023 Strasbourg, France

Medicine shortages are a growing problem that compromises patient care. Two key committees at the European Directorate for the Quality of Medicines & HealthCare (EDQM), the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH) and the European Pharmacopoeia Commission (EPC), are...

Read More

Revised general chapter 2.7.24 Flow cytometry in Pharmeuropa 35.4

EDQM 17/10/2023 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) is seeking stakeholder feedback on the revised general chapter Flow cytometry (2.7.24), published in this quarter’s issue of Pharmeuropa (35.4) for comment (public deadline 31 December 2023). The revision of this general chapter is of high importance since it...

Read More

Ph. Eur. pre-publishes Cannabis flower monograph on the EDQM website

EDQM 04/10/2023 Strasbourg, France

The new monograph on Cannabis flower (3028) was adopted at the 176th session of the European Pharmacopoeia (Ph. Eur.) Commission held on 20 and 21 June 2023. Given the exceptionally high interest from stakeholders in having access to the new text as soon as possible, the Ph. Eur. decided to make...

Read More

Pharmeuropa 35.4 just released

EDQM 04/10/2023 Strasbourg, France

All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 35.4 is 31 December 2023. Users and interested parties are welcome to comment on these drafts. It should...

Read More

European Pharmacopoeia Supplement 11.4 now available

EDQM 03/10/2023 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) Supplement 11.4 is now available and will be applicable in 39 European countries as of 1 April 2024. This volume is included in the 2024 subscription (11.3, 11.4 and 11.5) to the 11th Edition of the Ph. Eur. Subscriptions for print and/or electronic versions...

Read More

Ph. Eur. allows the use of recombinant factor C for control of bacterial endotoxins in water monographs

EDQM 13/092023 Strasbourg, France

Revised versions of the widely used monographs, Water for injections (0169) and Purified water (0008), will be published in Supplement 11.4 of the European Pharmacopoeia (Ph. Eur.). Adopted by the Ph. Eur. Commission at its 175th session in March this year, these two fundamental texts now allow...

Read More

N-nitrosamine impurities in Ph. Eur. monographs: update on approach

EDQM 24/07/2023 Strasbourg, France

Over the past few years, the texts of the European Pharmacopoeia (Ph. Eur.) have been adapted regularly to reflect the latest European regulatory requirements for N-nitrosamines. This included adding a Production statement covering the risk of N-nitrosamine formation to the Ph. Eur.’s five...

Read More

Outcome of the 176th session of the European Pharmacopoeia Commission, June 2023

EDQM 05/07/2023 Strasbourg, France

The European Pharmacopoeia Commission (EPC) held its 176th session on 20 and 21 June 2023. The 67 texts adopted at this session by the EPC will be published in European Pharmacopoeia (Ph. Eur.) Supplement 11.5 (January 2024), with an implementation date of 1 July 2024. These 67 texts included 11...

Read More

2022 Highlights – EDQM annual report now available

EDQM 05/06/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published its 2022 annual report, providing a comprehensive overview of its activities and achievements, and putting select data on the present state of EDQM/Council of Europe public health initiatives at your...

Read More

Pharmeuropa 35.3 just released

EDQM 03/07/2023 Strasbourg, France

All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 35.3 is 30 September 2023.

Read More

New Pharmeuropa Bio & Scientific Notes article now online: HCV RNA for NAT BRP replacement batch

EDQM 03/07/2023 Strasbourg, France

Following the successful completion of the Biological Standardisation Programme (BSP) study for the establishment of batch 2 of the Hepatitis C Virus (HCV) RNA for nucleic acid amplification techniques (NAT) Biological Reference Preparation (BRP), the outcome has been published in the online...

Read More

European Pharmacopoeia Supplement 11.3 now available

EDQM 01/07/2023 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) Supplement 11.3 is now available and will be applicable in 39 European countries as of 1 January 2024. This volume is included in the 2024 subscription (11.3, 11.4 and 11.5) to the 11th Edition of the Ph. Eur. Subscriptions for print and/or electronic...

Read More

Over 100 excipient monographs now with an FRC section in the Ph. Eur.

EDQM 30/06/2023 Strasbourg, France

European Pharmacopoeia (Ph. Eur.) Supplement 11.2, which comes into force in 39 European countries on 1 July 2023, contains five excipient monographs that have been revised to include a section on functionality-related characteristics (FRCs), boosting the total of Ph. Eur. monographs that include...

Read More

EDQM publishes 2nd edition of Herbal Guide

EDQM 07/06/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has just published a new edition of the Guide for the elaboration of monographs on herbal drugs and herbal drug preparations. This guide is invaluable for the authors of monographs on these substances, and also helps users...

Read More

Ph. Eur. Commission keeps pace with veterinary vaccine development efforts

EDQM 02/06/2023 Strasbourg, France

The first DNA vaccine granted a marketing authorisation in the European Union (EU) dates back to 2016 and is intended to protect Atlantic salmon against salmon pancreas disease (SPD) caused by salmon alphavirus subtype 3. Veterinary vaccine manufacturers have been developing third generation...

Read More

Call for Experts - NANO Working Party (Nanomedicines)

EDQM 01/06/2023 Strasbourg, France

In June 2022, the EDQM organised and hosted a symposium on “Quality requirements for nanomedicines – what role should the European Pharmacopoeia (Ph. Eur.) play?’’, during which the participants expressed a strong interest in having texts on nanomedicines available in the...

Read More

European Pharmacopoeia welcomes Kyrgyz Republic as observer state

EDQM 31/05/2023 Strasbourg, France

The European Pharmacopoeia Commission has granted observer status to the Kyrgyz Republic. This decision demonstrates the dynamism of the European Pharmacopoeia (Ph. Eur.), which now has 32 observers from around the world in addition to 39 European countries and the European Union as signatory...

Read More

Current options for shipping to Ukraine

EDQM 22/05/2023 Strasbourg, France

The EDQM is able to offer several options for shipments to Ukraine. Please consult the linked table: “EDQM shipping options for Ukraine”.

Read More